Summary
The product Dianabol (Methandienone), manufactured by Helion Labs, underwent independent testing to verify its authenticity and potency. The sample, identified as Dianabol, was submitted by Helion Labs and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis confirmed the presence of Methandienone with measured concentrations of 26.97 mg and 27.16 mg.
The testing process began on 3 June 2024, with the sample received on 4 July 2024, and the analysis completed on 10 July 2024. While the results confirm the product’s composition, scrutiny of manufacturer-submitted samples remains essential to ensure reliability. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Helion Labs
- Product Name: Dianabol
- Active Ingredient: Methandienone
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Oral
Sample Acquisition and Testing
- Task Number: #44941
- Testing Ordered: 3 June 2024
- Sample Received: 4 July 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Helion Labs (Manufacturer)
- Analysis Paid For By: Helion Labs (Manufacturer)
Testing Results
- Specification: 25 mg
- Measured Concentration: 26.97 mg; 27.16 mg
- Accuracy: Not available (No reference dosage stated)
Verification Details
- Verification URL: https://janoshik.com/tests/44941_ZW5B67W6PL8D
Evaluation of Manufacturer-Submitted Testing
This analysis confirms the presence of Methandienone in the tested product but highlights the need for careful evaluation due to manufacturer-submitted samples. Since Helion Labs both submitted and funded the test, further independent verification is recommended to assess batch-to-batch consistency. While Janoshik Analytical is known for its transparency and rigorous testing protocols, these findings would benefit from additional third-party testing across multiple samples.
Conclusion
The analysis verifies that the product contains Methandienone with measured concentrations of 26.97 mg and 27.16 mg. While this confirms the expected composition, independent testing remains necessary to ensure consistency across batches. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding pharmaceutical products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
